Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Autor: Ronald Boellaard, Alexander Drzezga, Christian la Fougère, Karl-Josef Langen, Nathalie L. Albert, Ian Law, Val J. Lowe, Jonathan McConathy, Harald H. Quick, Jörg C. Tonn, Javier Arbizu, David M. Schuster, Egesta Lopci, Norbert Galldiks, Bernhard Sattler, Michael Weller
Přispěvatelé: Guided Treatment in Optimal Selected Cancer Patients (GUTS), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), CCA - Imaging and biomarkers, Amsterdam Neuroscience - Brain Imaging, Radiology and nuclear medicine, ACS - Heart failure & arrhythmias
Rok vydání: 2018
Předmět:
Ciencias de la Salud::Radiología [Materias Investigacion]
Positron-Emission Tomography/standards
030218 nuclear medicine & medical imaging
0302 clinical medicine
Recurrence
Glioma/diagnostic imaging
Image Processing
Computer-Assisted
Amino Acids
Child
Societies
Medical
medicine.diagnostic_test
HIGH-GRADE
Glioma
General Medicine
Reference Standards
ATTENUATION CORRECTION
Dihydroxyphenylalanine
Tumor Burden
RECURRENT MALIGNANT GLIOMA
Research Design
Positron emission tomography
Isotope Labeling
030220 oncology & carcinogenesis
Practice Guidelines as Topic
MET
Adult
Quality Control
medicine.medical_specialty
BRAIN-TUMORS
FDG
F-18-FET PET
Context (language use)
Guidelines
Appropriate use
03 medical and health sciences
POSITRON-EMISSION-TOMOGRAPHY
Fluorodeoxyglucose F18
medicine
Humans
Radiology
Nuclear Medicine and imaging
Medical physics
In patient
C-11-METHIONINE PET
ddc:610
O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET
business.industry
CENTRAL-NERVOUS-SYSTEM
Neurooncology
FET
Pet imaging
medicine.disease
FDOPA
PET
Positron-Emission Tomography
Nuclear Medicine
Molecular imaging
business
EANM PROCEDURE GUIDELINES
Zdroj: Law, I, Albert, N L, Arbizu, J, Boellaard, R, Drzezga, A, Galldiks, N, la Fougère, C, Langen, K-J, Lopci, E, Lowe, V, McConathy, J, Quick, H H, Sattler, B, Schuster, D M, Tonn, J-C & Weller, M 2019, ' Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG : version 1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 3, pp. 540-557 . https://doi.org/10.1007/s00259-018-4207-9
Law, I, Albert, N L, Arbizu, J, Boellaard, R, Drzezga, A, Galldiks, N, la Fougère, C, Langen, K-J, Lopci, E, Lowe, V, McConathy, J, Quick, H H, Sattler, B, Schuster, D M, Tonn, J-C & Weller, M 2019, ' Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ 18 F]FDG : version 1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 3, pp. 540-557 . https://doi.org/10.1007/s00259-018-4207-9
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
European journal of nuclear medicine and molecular imaging 46(3), 540–557 (2019). doi:10.1007/s00259-018-4207-9
European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 540-557. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 540-557. Springer Verlag
ISSN: 1619-7089
1619-7070
DOI: 10.1007/s00259-018-4207-9
Popis: These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations.
Databáze: OpenAIRE
Externí odkaz: